171 related articles for article (PubMed ID: 34119534)
1. Effect of liraglutide on microcirculation in rat model with absolute insulin deficiency.
Ivanov AN; Lagutina DD; Saveleva MS; Popyhova EB; Stepanova TV; Savkina AA; Pylaev TE; Kuznetsova NA
Microvasc Res; 2021 Nov; 138():104206. PubMed ID: 34119534
[TBL] [Abstract][Full Text] [Related]
2. Adverse vascular remodelling is more sensitive than endothelial dysfunction to hyperglycaemia in diabetic rat mesenteric arteries.
Kahlberg N; Qin CX; Anthonisz J; Jap E; Ng HH; Jelinic M; Parry LJ; Kemp-Harper BK; Ritchie RH; Leo CH
Pharmacol Res; 2016 Sep; 111():325-335. PubMed ID: 27363948
[TBL] [Abstract][Full Text] [Related]
3. Strict glycaemic control improves skin microcirculation in patients with type 2 diabetes: a report from the Diabetes mellitus And Diastolic Dysfunction (DADD) study.
Jarnert C; Kalani M; Rydén L; Böhm F
Diab Vasc Dis Res; 2012 Oct; 9(4):287-95. PubMed ID: 22377484
[TBL] [Abstract][Full Text] [Related]
4. Impaired endothelium-dependent skin microvascular function during high-dose atorvastatin treatment in patients with type 1 diabetes.
Tehrani S; Mobarrez F; Lins PE; Adamson U; Wallén HN; Jörneskog G
Diab Vasc Dis Res; 2013 Nov; 10(6):483-8. PubMed ID: 23823849
[TBL] [Abstract][Full Text] [Related]
5. Renoprotective effect of GLP-1 receptor agonist, liraglutide, in early-phase diabetic kidney disease in spontaneously diabetic Torii fatty rats.
Yamada S; Tanabe J; Ogura Y; Nagai Y; Sugaya T; Ohata K; Natsuki Y; Ichikawa D; Watanabe S; Inoue K; Hoshino S; Kimura K; Shibagaki Y; Kamijo-Ikemori A
Clin Exp Nephrol; 2021 Apr; 25(4):365-375. PubMed ID: 33409761
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effect of glucagon-like peptide-1 receptor agonist is independent of glycaemia normalization in type two diabetic rats.
Filchenko I; Simanenkova A; Chefu S; Kolpakova M; Vlasov T
Diab Vasc Dis Res; 2018 Nov; 15(6):567-570. PubMed ID: 30024276
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic factors for the carbohydrate metabolism normalization in patients with type 2 diabetes mellitus and obesity using liraglutide 3.0 mg per day].
Sklyanik IA; Shestakova MV
Ter Arkh; 2021 Oct; 93(10):1203-1208. PubMed ID: 36286822
[TBL] [Abstract][Full Text] [Related]
8. Liraglutide treatment improves the coronary microcirculation in insulin resistant Zucker obese rats on a high salt diet.
Sukumaran V; Tsuchimochi H; Sonobe T; Waddingham MT; Shirai M; Pearson JT
Cardiovasc Diabetol; 2020 Feb; 19(1):24. PubMed ID: 32093680
[TBL] [Abstract][Full Text] [Related]
9. GLP-1-Based Therapies Have No Microvascular Effects in Type 2 Diabetes Mellitus: An Acute and 12-Week Randomized, Double-Blind, Placebo-Controlled Trial.
Smits MM; Tonneijck L; Muskiet MH; Hoekstra T; Kramer MH; Diamant M; Serné EH; van Raalte DH
Arterioscler Thromb Vasc Biol; 2016 Oct; 36(10):2125-32. PubMed ID: 27562916
[TBL] [Abstract][Full Text] [Related]
10. Uric acid levels are associated with microvascular endothelial dysfunction in patients with Type 1 diabetes.
Matheus AS; Tibiriçá E; da Silva PB; de Fátima Bevilácqua da Matta M; Gomes MB
Diabet Med; 2011 Oct; 28(10):1188-93. PubMed ID: 21658123
[TBL] [Abstract][Full Text] [Related]
11. Effects of insulin analogs as an add-on to metformin on cutaneous microcirculation in type 2 diabetic patients.
Fysekidis M; Cosson E; Takbou K; Sutton A; Charnaux N; Banu I; Vicaut E; Valensi P
Microvasc Res; 2018 Mar; 116():6-14. PubMed ID: 28954218
[TBL] [Abstract][Full Text] [Related]
12. Comparison of skin microvascular reactivity with hemostatic markers of endothelial dysfunction and damage in type 2 diabetes.
Beer S; Feihl F; Ruiz J; Juhan-Vague I; Aillaud MF; Wetzel SG; Liaudet L; Gaillard RC; Waeber B
Vasc Health Risk Manag; 2008; 4(6):1449-58. PubMed ID: 19337558
[TBL] [Abstract][Full Text] [Related]
13. Liraglutide Treatment Reduces Endothelial Endoplasmic Reticulum Stress and Insulin Resistance in Patients With Diabetes Mellitus.
Bretón-Romero R; Weisbrod RM; Feng B; Holbrook M; Ko D; Stathos MM; Zhang JY; Fetterman JL; Hamburg NM
J Am Heart Assoc; 2018 Sep; 7(18):e009379. PubMed ID: 30371206
[TBL] [Abstract][Full Text] [Related]
14. Catechin averts experimental diabetes mellitus-induced vascular endothelial structural and functional abnormalities.
Bhardwaj P; Khanna D; Balakumar P
Cardiovasc Toxicol; 2014 Mar; 14(1):41-51. PubMed ID: 24048981
[TBL] [Abstract][Full Text] [Related]
15. Glucagon-like peptide 1 receptor agonists in type 1 diabetes mellitus.
Guyton J; Jeon M; Brooks A
Am J Health Syst Pharm; 2019 Oct; 76(21):1739-1748. PubMed ID: 31612934
[TBL] [Abstract][Full Text] [Related]
16. Impact of liraglutide on microcirculation in experimental diabetic cardiomyopathy.
Abdelrazik Soliman NG; Abdel-Hamid AAM; El-Hawwary AA; Ellakkany A
Acta Histochem; 2020 Apr; 122(3):151533. PubMed ID: 32197755
[TBL] [Abstract][Full Text] [Related]
17. Treatment of streptozotocin-induced diabetic rats with alogliptin: effect on vascular and neural complications.
Davidson EP; Coppey LJ; Dake B; Yorek MA
Exp Diabetes Res; 2011; 2011():810469. PubMed ID: 21822422
[TBL] [Abstract][Full Text] [Related]
18. Liraglutide prevents microvascular insulin resistance and preserves muscle capillary density in high-fat diet-fed rats.
Chai W; Fu Z; Aylor KW; Barrett EJ; Liu Z
Am J Physiol Endocrinol Metab; 2016 Sep; 311(3):E640-8. PubMed ID: 27436611
[TBL] [Abstract][Full Text] [Related]
19. Glutamine up-regulates pancreatic sodium-dependent neutral aminoacid transporter-2 and mitigates islets apoptosis in diabetic rats.
Medras ZJH; El-Sayed NM; Zaitone SA; Toraih EA; Sami MM; Moustafa YM
Pharmacol Rep; 2018 Apr; 70(2):233-242. PubMed ID: 29475006
[TBL] [Abstract][Full Text] [Related]
20. Effect of vitamin D on aortic remodeling in streptozotocin-induced diabetes.
Salum E; Kampus P; Zilmer M; Eha J; Butlin M; Avolio AP; Põdramägi T; Arend A; Aunapuu M; Kals J
Cardiovasc Diabetol; 2012 Jul; 11():58. PubMed ID: 22631050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
